Brunkhorst R, Fromm S, Wrenger E, Berke A, Petersen R, Riede G, Westphale J, Zamore E, Ledebo I
Division of Nephrology, Medizinische Hochschule Hannover, Germany.
Nephrol Dial Transplant. 1998 Dec;13(12):3189-92. doi: 10.1093/ndt/13.12.3189.
Automated peritoneal dialysis (APD) has the possibility of increasing the dialysis efficacy by using higher fill volumes, frequent dialysate exchanges, and tidal techniques. It is then possible to treat patients adequately without residual renal function. The drawbacks of the required high amounts of dialysis solution of up to 30 litres per session are the high costs of lactate-based dialysate bags and difficulties for the patients in handling these bags. So far, bicarbonate-based peritoneal dialysate, which may be more biocompatible, is only available for CAPD in double-chamber bags. In APD this could be overcome by 'on-line' preparation of bicarbonate-buffered dialysate using advanced technologies originally designed for on-line preparation of substitution fluid for haemofiltration.
Four patients without residual renal function were treated with APD five times weekly in a crossover study design. Patients received standard lactate-based (35 mmol/l) treatment (25 litres per session each) in weeks 1 and 3. In week 2 on-line-produced bicarbonate-buffered (37 mmol/l) dialysate was used. This dialysate was prepared by an AK 100 Ultra haemodialysis machine. The machine was modified for adding glucose from a 50% concentrate to the desired concentration of 1.7%. Electrolytes, pH, pCO2, and dialysis efficacy parameters were measured. Microbiological testing was carefully performed.
Creatinine clearances, Kt/V, and pCO2 did not vary between the different treatment phases, whereas the pH showed a distinct increase during the bicarbonate phase. Repeated determinations of endotoxins and culturing showed no contamination of the dialysate. The composition of the produced dialysate was reproducible with respect to pH, pCO2, sodium, calcium and bicarbonate, whereas the glucose concentration varied by +/- 20%.
On-line preparation of PD fluid with the AK 100 Ultra is easy and safe to handle. APD with dialysate containing 37 mmol/l bicarbonate provides improved acid base balance and possibly improved biocompatibility, and may lead to a significant cost reduction. Further development in order to provide smaller machines and more precise ways of achieving a desired dialysate glucose concentration is necessary.
自动化腹膜透析(APD)通过使用更高的填充量、频繁的透析液交换和潮式技术,有可能提高透析效果。这样就有可能在患者没有残余肾功能的情况下对其进行充分治疗。每次治疗需要高达30升透析液的缺点是基于乳酸盐的透析液袋成本高昂,且患者处理这些袋子存在困难。到目前为止,可能具有更高生物相容性的基于碳酸氢盐的腹膜透析液仅以双腔袋形式用于持续性非卧床腹膜透析(CAPD)。在APD中,可以通过使用最初设计用于在线制备血液滤过置换液的先进技术“在线”制备碳酸氢盐缓冲透析液来克服这一问题。
在一项交叉研究设计中,对4例无残余肾功能的患者每周进行5次APD治疗。患者在第1周和第3周接受标准的基于乳酸盐(35 mmol/L)的治疗(每次治疗25升)。在第2周,使用在线生产的碳酸氢盐缓冲(37 mmol/L)透析液。这种透析液由一台AK 100 Ultra血液透析机制备。对该机器进行了改装,以便从50%的浓缩液中添加葡萄糖至所需浓度1.7%。测量了电解质、pH值、pCO2和透析效果参数。仔细进行了微生物检测。
肌酐清除率、Kt/V和pCO2在不同治疗阶段之间没有变化,而pH值在碳酸氢盐阶段有明显升高。对内毒素的重复测定和培养显示透析液没有污染。所制备透析液的成分在pH值、pCO2、钠、钙和碳酸氢盐方面具有可重复性,而葡萄糖浓度的变化为±20%。
使用AK 100 Ultra在线制备腹膜透析液操作简便且安全。使用含37 mmol/L碳酸氢盐的透析液进行APD可改善酸碱平衡,并可能提高生物相容性,还可能显著降低成本。有必要进一步研发以提供更小的机器以及更精确的方法来达到所需的透析液葡萄糖浓度。